Model 1* | Model 2† | ||||||||||||
All patients | Male | Female | All patients | Male | Female | ||||||||
HR | CI | HR | CI | HR | CI | HR | CI | HR | CI | HR | CI | ||
Stage IA–IV | Education | ||||||||||||
Low | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | |
Middle | 0.97 | 0.88 to 1.06 | 1.02 | 0.91 to 1.15 | 0.88 | 0.76 to 1.01 | 0.99 | 0.89 to 1.09 | 1.05 | 0.92 to 1.19 | 0.91 | 0.78 to 1.07 | |
High | 0.94 | 0.81 to 1.08 | 1.05 | 0.88 to 1.25 | 0.76 | 0.60 to 0.96 | 1.02 | 0.87 to 1.19 | 1.12 | 0.92 to 1.36 | 0.84 | 0.65 to 1.08 | |
Stage IA–IIB | Education | ||||||||||||
Low | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | |
Middle | 0.69 | 0.55 to 0.87 | 0.79 | 0.59 to 1.06 | 0.58 | 0.40 to 0.83 | 0.69 | 0.55 to 0.88 | 0.76 | 0.56 to 1.04 | 0.65 | 0.44 to 0.96 | |
High | 0.58 | 0.40 to 0.85 | 0.77 | 0.5 to 1.19 | 0.28 | 0.13 to 0.62 | 0.70 | 0.47 to 1.03 | 0.95 | 0.60 to 1.51 | 0.33 | 0.14 to 0.77 | |
Stage IIIA–IIIB | Education | ||||||||||||
Low | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | |
Middle | 0.94 | 0.81 to 1.08 | 0.96 | 0.80 to 1.15 | 0.88 | 0.69 to 1.11 | 0.97 | 0.83 to 1.14 | 1.04 | 0.85 to 1.28 | 0.89 | 0.69 to 1.15 | |
High | 1.18 | 0.95 to 1.47 | 1.34 | 1.02 to 1.76 | 0.93 | 0.64 to 1.34 | 1.30 | 1.03 to 1.65 | 1.41 | 1.04 to 1.90 | 1.08 | 0.74 to 1.59 | |
Stage IV | Education | ||||||||||||
Low | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | |
Middle | 1.09 | 0.96 to 1.26 | 1.15 | 0.96 to 1.38 | 1.04 | 0.84 to 1.29 | 1.12 | 0.96 to 1.31 | 1.15 | 0.94 to 1.42 | 1.13 | 0.89 to 1.45 | |
High | 0.95 | 0.76 to 1.17 | 1.00 | 0.76 to 1.33 | 0.86 | 0.61 to 1.22 | 0.98 | 0.77 to 1.25 | 1.04 | 0.75 to 1.43 | 0.92 | 0.62 to 1.37 |